Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today [...]
Precision Study Underway – 100 Prostate Cancer Patients Treated in Just 3 Radiation Sessions
“The goal of the Precision Study is to ensure that [...]
City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
“This is an exciting new application of a known medication [...]
REGENXBIO Reports Positive Biomarker Data from the AFFINITY DUCHENNE ®Trial of RGX-202 Gene Therapy
“RGX-202 is the only next generation gene therapy for Duchenne [...]
Science behind “Polly Want a Cracker” Could Guide Future Treatment Design for Speech Disorders
Published online March 19 in the journal Nature, the study [...]
Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury [...]
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
The Audiogene trial is designed to evaluate the safety, tolerability [...]
New Clinical Trial Regulations Set to Speed up Medical Innovation
This article gives an overview of the new clinical trial [...]
Unveiling the Future of Neuropathy Treatment: NEUBIE Device Shows Remarkable Results
“Neuropathy is incredibly common among the aging population, regardless of [...]
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Dr. Joel Braunstein, CEO of C2N Diagnostics, says, “This research [...]